Esperion Therapeutics, Inc. (ESPR)
3.135
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
3.13
0.00 (0.00%)
After-Hours: 06:04
Esperion Therapeutics Profit Margin (Quarterly) : -31.45% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | -26.19% |
| Nektar Therapeutics | -413.4% |
| Harrow, Inc. | -62.44% |
| Corcept Therapeutics, Inc. | -18.92% |
| Eli Lilly & Co. | 37.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -1.56% |
| Return on Invested Capital | -3.85% |
| Gross Profit Margin (Quarterly) | 56.84% |
| Operating Margin (Quarterly) | -8.22% |
| Return on Net Operating Assets | -2.81% |